Jackson Creek Investment Advisors LLC Abb Vie Inc. Transaction History

Jackson Creek Investment Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$159.82 - $182.1 $96,371 - $109,806	603 Added 42.02%	2,038 $371,000
Q3 2023 Nov 03, 2023	BUY	$133.59 - $154.65 $191,701 - $221,922	1,435 New	1,435 $214,000
Q2 2022 Aug 04, 2022	SELL	$137.62 - $174.96 $273,175 - $347,295	-1,985 Closed	0 $0
Q3 2021 Nov 02, 2021	SELL	$106.4 - $120.78 $8,299 - $9,420	-78 Reduced 3.78%	1,985 $214,000
Q2 2021 Aug 03, 2021	BUY	$105.21 - $117.21 $217,048 - $241,804	2,063 New	2,063 $232,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Jackson Creek Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Jackson Creek Investment Advisors LLC with notifications on news.